Uterine cancer Treatment in Uni-asia Cancer hospital

Uni-asia Cancer Hospital in Chengdu, China, provides specialized care for uterine cancer using a multidisciplinary team approach. Patients can access diagnostics ranging from online consultations for around $150 to full-body PET/CT scans costing around $1,300. The oncology department is led by Prof. Liao Zhengyin, who brings over 30 years of experience and formerly directed the Cancer Center at West China Hospital.

Diagnostic and consultation options

The hospital uses several methods to confirm a diagnosis and determine the stage of the cancer. An online consultation with an oncologist costs around $150 and helps patients get expert advice before traveling. A whole-body CT scan or a PET/CT scan typically runs around $1,300 to check for the spread of the disease. Other available diagnostic tools include:

• Hysteroscopy with endometrial biopsy. This gold-standard procedure allows doctors to view the uterus and take tissue samples.
• Transvaginal ultrasound. This test checks the thickness of the uterine lining.
• MRI scan. Doctors use this to see how deeply the tumor has grown into the muscle.
• CA-125 serum test. This blood test helps monitor for signs of cancer activity.

Surgical and minimally invasive treatments

Surgery is the primary treatment for early-stage uterine cancer. The clinic offers extrafascial total hysterectomy and bilateral adnexectomy, which involves removing the uterus and ovaries. The surgical team also performs lymph node dissection if pathology results show it is necessary.

For patients who prefer less invasive options, the hospital uses laparoscopic or robot-assisted surgery. These methods involve smaller incisions, which leads to less trauma and faster recovery. Young patients with early-stage cancer may choose fertility-preserving hysteroscopic resection combined with high-dose progestin therapy to maintain their ability to have children.

Advanced therapy and specialist expertise

Prof. Liao Zhengyin leads the treatment team. He served as a senior visiting scholar at Johns Hopkins Hospital and is a leading figure in tumor therapy in China. Under his direction, the hospital provides specialized systemic and radiation treatments:

• Targeted and immunotherapy. These drugs, including immune checkpoint inhibitors, help treat specific tumor mutations like MSI-H.
• Endocrine therapy. Doctors use progestins for patients needing fertility preservation or for those with recurrent disease.
• Postoperative chemoradiotherapy. This combined approach helps reduce the risk of cancer returning in high-risk patients.
• Ablation techniques. The facility uses NanoKnife, cryoablation, and microwave ablation for specific tumor cases.

The hospital features 600 beds and 80 private rooms across two campuses. Patients interested in these options can request a consultation through Bookimed.